From established players to up-and-coming firms, Canada’s pharmaceutical company is diverse and dynamic.
Canadian pharma companies are working to discover and develop major innovations amidst an increasingly competitive global landscape. Rising technologies such as artificial intelligence are playing a role in the landscape as well.
Year-on-year gain: 124.64 percent; market cap: C$310.38 million; share price: C$12.40
Year-on-year gain: 103.99 percent; market cap: C$30.71 million; share price: C$0.60
Year-on-year gain: 93.75 percent; market cap: C$25.7 million; share price: C$0.47
Telescope Innovations is a chemical technology company that develops scalable manufacturing processes and tools that combine robotic automation, online analysis and machine learning for the pharmaceutical and chemical industries.
The company has commercialized its DirectInject-LC system. Short for Direct Inject Liquid Chromatography, the system combines hardware and software to analyze chemical reactions and can potentially reduce the time and cost of new drug development.
Securities Disclosure: I, Meagen Seatter, hold no direct investment interest in any company mentioned in this article.
Leave a Reply